Clinical Trial Update: GLP-1 RA on Liver OMICS in MASLD

View source ↗

Summary

This clinical trial update describes a study evaluating GLP-1 receptor agonists on liver omics in MASLD/NAFLD, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Non-alcoholic Fatty Liver Disease
• Obesity

Snippet

Sponsor: Medical College of Wisconsin | Conditions: NAFLD, Diabetes | Status: NOT_YET_RECRUITING